Azenosertib
Ovarian Serous Cystadenocarcinoma
Explore 6 assets in Ovarian Serous Cystadenocarcinoma →K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, IncSmall moleculePhase 2
—
Rating in progress
Azenosertib in Ovarian Serous Cystadenocarcinoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active